Mike Sung
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
- Cancer survivorship and care
- Lung Cancer Research Studies
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 9
- Lung Cancer Diagnosis and Treatment 2
- Oncology 9
- Cancer Immunotherapy and Biomarkers 4
- Lung Cancer Research Studies 3
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Natasha B. Leighl (13 shared papers)Frances A. Shepherd (7 shared papers)Ronald Feld (4 shared papers)Geoffrey Liu (6 shared papers)Lisa W. Le (7 shared papers)Penelope A. Bradbury (4 shared papers)Leila Khoja (2 shared papers)Catherine Labbé (2 shared papers)
- Journals
- Journal of Thoracic Oncology (3 papers)Clinical Lung Cancer (2 papers)Value in Health (1 paper)Journal of Clinical Oncology (1 paper)Lung Cancer (1 paper)
- Partner nations
- CanadaUnited KingdomUnited States
In The Last Decade
Mike Sung
16 papers receiving 312 citations
Peers
Comparison fields: 5 of 58
- Oncology 234
- Pulmonary and Respiratory Medicine 149
- Cancer Research 54
- Otorhinolaryngology 7
- Pediatrics, Perinatology and Child Health 31
Countries citing papers authored by Mike Sung
This map shows the geographic impact of Mike Sung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Sung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Sung more than expected).
Fields of papers citing papers by Mike Sung
This network shows the impact of papers produced by Mike Sung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Sung. The network helps show where Mike Sung may publish in the future.
Co-authors
The 25 scholars most cited alongside Mike Sung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 102 | |
| 2 | 2017 | 73 | |
| 3 | 2016 | 47 | |
| 4 | 2020 | 31 | |
| 5 | 2020 | 23 | |
| 6 | 2022 | 11 | |
| 7 | 2018 | 9 | |
| 8 | 2016 | 5 | |
| 9 | 2020 | 4 | |
| 10 | 2017 | 4 | |
| 11 | 2021 | 3 | |
| 12 | 2019 | 2 | |
| 13 | 2020 | 1 | |
| 14 | 2024 | 1 | |
| 15 | 2017 | 1 | |
| 16 | 2019 | 1 | |
| 17 | A technology for corrosion protection | 2011 | 0 |
| 18 | 2024 | 0 |
About Mike Sung
Mike Sung is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Artificial Intelligence and Radiology, Nuclear Medicine and Imaging, having authored 18 papers that have together received 318 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Genomics and Diagnostics (4 papers), Lung Cancer Research Studies (3 papers), Radiomics and Machine Learning in Medical Imaging (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Natural Language Processing Techniques (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (234 citations), Pulmonary and Respiratory Medicine (149 citations), Cancer Research (54 citations), Otorhinolaryngology (7 citations) and Pediatrics, Perinatology and Child Health (31 citations). Mike Sung has collaborated with scholars based in Canada, United Kingdom and United States. Frequent co-authors include Natasha B. Leighl, Frances A. Shepherd, Ronald Feld, Geoffrey Liu, Lisa W. Le, Penelope A. Bradbury, Leila Khoja, Catherine Labbé, Manjula Maganti and Alona Zer. Their work appears in journals such as Journal of Thoracic Oncology, Clinical Lung Cancer, Value in Health, Journal of Clinical Oncology and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.